# Study of DS-5141b in Patients With Duchenne Muscular Dystrophy

> **NCT02667483** · PHASE1,PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 8 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** DS-5141b

## Key facts

- **NCT ID:** NCT02667483
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2020-10-20
- **Final completion:** 2020-10-20
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02667483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02667483, "Study of DS-5141b in Patients With Duchenne Muscular Dystrophy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02667483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*